Carlos González-Nuñez, Alejandro Mohar, Nancy Reynoso-Noverón, Rosa María Alvarez-Gómez, Yanin Chavarri-Guerra, Sergio Aguilar-Villanueva, Raúl Guzmán-Trigueros, Areli Velázquez-Martínez, Talía Wegman-Ostrosky, Fanny Porras-Reyes, Alexandra Garcilazo, Claudia Arce, Juan Enrique Bargallo-Rocha, Paula Cabrera-Galeana
{"title":"拉丁裔男性乳腺癌患者的临床特征。","authors":"Carlos González-Nuñez, Alejandro Mohar, Nancy Reynoso-Noverón, Rosa María Alvarez-Gómez, Yanin Chavarri-Guerra, Sergio Aguilar-Villanueva, Raúl Guzmán-Trigueros, Areli Velázquez-Martínez, Talía Wegman-Ostrosky, Fanny Porras-Reyes, Alexandra Garcilazo, Claudia Arce, Juan Enrique Bargallo-Rocha, Paula Cabrera-Galeana","doi":"10.1007/s10549-024-07525-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Breast cancer is the most prevalent cancer type in Mexico, with male breast cancer accounting for only 1% of all breast cancer cases. A limited number of studies have described the clinical-pathological profiles of males with breast cancer in low- and middle-income countries. This study presents an analysis of patients with breast cancer seen at three different institutions in México.</p><p><strong>Methods: </strong>A retrospective review of the medical records was performed to analyze the clinical and pathological characteristics of 49 men diagnosed with breast cancer and their overall survival.</p><p><strong>Results: </strong>The mean age at diagnosis was 64.65 years. A significant proportion of patients presented at diagnosis with stage IV disease (n = 11, 22.45%), had triple-negative subtype (n = 6, 12.24%), and nuclear grade III (n = 20, 40.8%). Primary endocrine resistance was observed in 10 patients (31.25%). Genetic analysis was performed on 24 patients (48.9%), revealing a germline BRCA pathogenic variant in 8.33%.</p><p><strong>Conclusion: </strong>Our findings described the clinical and pathological profile of breast cancer in a male cohort in Mexico, with a significantly high proportion of advanced disease, triple-negative subtype, nuclear grade III, and endocrine resistance. Further comprehensive studies, including research into somatic mutations, are needed.</p>","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical characteristics of male patients with breast cancer in the Latino population.\",\"authors\":\"Carlos González-Nuñez, Alejandro Mohar, Nancy Reynoso-Noverón, Rosa María Alvarez-Gómez, Yanin Chavarri-Guerra, Sergio Aguilar-Villanueva, Raúl Guzmán-Trigueros, Areli Velázquez-Martínez, Talía Wegman-Ostrosky, Fanny Porras-Reyes, Alexandra Garcilazo, Claudia Arce, Juan Enrique Bargallo-Rocha, Paula Cabrera-Galeana\",\"doi\":\"10.1007/s10549-024-07525-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Breast cancer is the most prevalent cancer type in Mexico, with male breast cancer accounting for only 1% of all breast cancer cases. A limited number of studies have described the clinical-pathological profiles of males with breast cancer in low- and middle-income countries. This study presents an analysis of patients with breast cancer seen at three different institutions in México.</p><p><strong>Methods: </strong>A retrospective review of the medical records was performed to analyze the clinical and pathological characteristics of 49 men diagnosed with breast cancer and their overall survival.</p><p><strong>Results: </strong>The mean age at diagnosis was 64.65 years. A significant proportion of patients presented at diagnosis with stage IV disease (n = 11, 22.45%), had triple-negative subtype (n = 6, 12.24%), and nuclear grade III (n = 20, 40.8%). Primary endocrine resistance was observed in 10 patients (31.25%). Genetic analysis was performed on 24 patients (48.9%), revealing a germline BRCA pathogenic variant in 8.33%.</p><p><strong>Conclusion: </strong>Our findings described the clinical and pathological profile of breast cancer in a male cohort in Mexico, with a significantly high proportion of advanced disease, triple-negative subtype, nuclear grade III, and endocrine resistance. Further comprehensive studies, including research into somatic mutations, are needed.</p>\",\"PeriodicalId\":9133,\"journal\":{\"name\":\"Breast Cancer Research and Treatment\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-10-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Cancer Research and Treatment\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10549-024-07525-1\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-024-07525-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:乳腺癌是墨西哥发病率最高的癌症类型,而男性乳腺癌仅占所有乳腺癌病例的 1%。在低收入和中等收入国家,描述男性乳腺癌患者临床病理特征的研究数量有限。本研究对在墨西哥三家不同机构就诊的乳腺癌患者进行了分析:方法:对医疗记录进行回顾性审查,分析 49 名确诊为乳腺癌的男性患者的临床和病理特征及其总生存率:结果:确诊时的平均年龄为 64.65 岁。结果:确诊时的平均年龄为 64.65 岁,相当一部分患者在确诊时处于 IV 期(11 人,占 22.45%),三阴性亚型(6 人,占 12.24%),核分级为 III 级(20 人,占 40.8%)。10名患者(31.25%)出现原发性内分泌抵抗。对24名患者(48.9%)进行了基因分析,发现8.33%的患者存在种系BRCA致病变异:我们的研究结果描述了墨西哥男性群体中乳腺癌的临床和病理特征,其中晚期疾病、三阴性亚型、核分级 III 级和内分泌抵抗的比例明显较高。需要进一步开展全面研究,包括对体细胞突变的研究。
Clinical characteristics of male patients with breast cancer in the Latino population.
Purpose: Breast cancer is the most prevalent cancer type in Mexico, with male breast cancer accounting for only 1% of all breast cancer cases. A limited number of studies have described the clinical-pathological profiles of males with breast cancer in low- and middle-income countries. This study presents an analysis of patients with breast cancer seen at three different institutions in México.
Methods: A retrospective review of the medical records was performed to analyze the clinical and pathological characteristics of 49 men diagnosed with breast cancer and their overall survival.
Results: The mean age at diagnosis was 64.65 years. A significant proportion of patients presented at diagnosis with stage IV disease (n = 11, 22.45%), had triple-negative subtype (n = 6, 12.24%), and nuclear grade III (n = 20, 40.8%). Primary endocrine resistance was observed in 10 patients (31.25%). Genetic analysis was performed on 24 patients (48.9%), revealing a germline BRCA pathogenic variant in 8.33%.
Conclusion: Our findings described the clinical and pathological profile of breast cancer in a male cohort in Mexico, with a significantly high proportion of advanced disease, triple-negative subtype, nuclear grade III, and endocrine resistance. Further comprehensive studies, including research into somatic mutations, are needed.
期刊介绍:
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.